The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence to assess the impact of resources produced under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and closes on 26 February 2027.
The two organisations are inviting responses from across the sector: developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
According to the MHRA and NICE, the exercise forms part of the programme's Phase 1 evaluation. It is intended to establish how the resources have been received and used across the sector, and in particular whether they have influenced users' knowledge, confidence, decision-making and professional practice.
The materials were designed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools. Responses will be used to determine whether the Phase 1 outputs achieved their intended objectives and to inform the future direction of Phase 2.
The agencies say participation is welcome whether respondents have engaged with the existing resources extensively, minimally or not at all. The feedback, they add, will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.